We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




OraSure Technologies to Purchase DNA Genotek for US$53 Million

By LabMedica International staff writers
Posted on 01 Aug 2011
OraSure Technologies, Inc. More...
(Bethlehem, PA, USA) will acquire privately held DNA Genotek Inc. (Ottawa, Canada), a leading provider of oral fluid sample collection, stabilization, and preparation products for molecular diagnostic applications. The transaction valued at approximately US$53 million is anticipated to close in the third quarter of 2011.

The acquisition of DNA Genotek will strengthen OraSure’s leadership in oral fluid diagnostics, by providing a complementary portfolio of products that enable easy and reliable collection, stabilization, transportation, and storage of high quality nucleic acid (DNA and RNA) samples. These samples can then be used for a wide range of diagnostic and research applications.

The Oragene•DNA sample collection kit is DNA Genotek's lead product, providing an all-in-one system for the collection, stabilization, transportation and purification of DNA from saliva. Genetic samples are collected using a simple, noninvasive method; collected samples may be transported and stored for extended periods at ambient temperatures.

DNA Genotek products are used in clinical genetic testing, pharmacogenomics, personalized medicine, academic research, animal genetics, and livestock genetics markets. DNA Genotek is a leading provider of oral fluid collection devices to the direct-to-consumer personal genetics testing market. The company supplies products that provide substantial advantages over traditional methods of sampling such as blood or buccal swabs.

OraSure Technologies is a leader in the development, manufacture, and distribution of oral fluid diagnostic devices and other technologies designed to diagnose critical medical conditions and diseases. Its innovative products include rapid tests for the detection of antibodies to Human Immunodeficiency virus (HIV) and Hepatitis C virus (HCV) at the point of care (POC) and testing solutions for detecting various drugs of abuse.

OraSure’s products are sold globally to various clinical laboratories, hospitals, clinics, community-based organizations, and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.

Related Links:

OraSure Technologies, Inc.
DNA Genotek Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Thyroid Test
Anti-Thyroid EIA Test
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.